Healthcare Infection Control Practices Advisory Committee (HICPAC), 62636 [2013-24341]
Download as PDF
<![CDATA[
62636
Federal Register / Vol. 78, No. 204 / Tuesday, October 22, 2013 / Notices
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC).
[FR Doc. 2013–24338 Filed 10–21–13; 8:45 am]
BILLING CODE 4163–18–P
Georgia 30333. Telephone (404) 639–4045.
Email: hicpac@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2013–24341 Filed 10–21–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
sroberts on DSK5SPTVN1PROD with FRONT MATTER
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following meeting for the
aforementioned committee:
Times and Dates: 9:00 a.m.–5:00 p.m.,
November 6, 2013; 9:00 a.m.–12:00 p.m.,
November 7, 2013.
Place: Centers for Disease Control and
Prevention, Global Communications Center,
Building 19, Auditorium B3, 1600 Clifton
Road NE., Atlanta, Georgia 30333.
Status: Open to the public, limited only by
the space available. Please register for the
meeting at www.cdc.gov/hicpac.
Purpose: The Committee is charged with
providing advice and guidance to the
Director, Division of Healthcare Quality
Promotion, the Director, National Center for
Emerging and Zoonotic Infectious Diseases
(NCEZID), the Director, CDC, the Secretary,
Health and Human Services regarding (1) the
practice of healthcare infection prevention
and control; (2) strategies for surveillance,
prevention, and control of infections,
antimicrobial resistance, and related events
in settings where healthcare is provided; and
(3) periodic updating of CDC guidelines and
other policy statements regarding prevention
of healthcare-associated infections and
healthcare-related conditions.
Matters To Be Discussed: The agenda will
include updates on CDC and Division of
Healthcare Quality Promotion’s (DHQP’s)
activities for prevention and surveillance of
healthcare associated infections (HAI) and
antimicrobial resistance, and developing a
process to define core infection prevention
and control methods. Also to be discussed is
the development of guidance for CDC
guideline recommendations that are
categorized as ‘‘unresolved’’.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information: Erin
Stone, M.S., HICPAC, Division of Healthcare
Quality Promotion, NCEZID, CDC, l600
Clifton Road NE., Mailstop A–07, Atlanta,
21:08 Oct 21, 2013
Jkt 232001
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2013–24340 Filed 10–21–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–10486]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
VerDate Mar<15>2010
Prevention and the Agency for Toxic
Substances and Disease Registry.
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Disease Control and
Prevention
ACTION:
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Cooperative Agreement on
Occupational Health with the World
Health Organization (WHO):
Implementing World Health Assembly
Resolution 60.26 Global Plan of Action
for Workers Health 2008–2017; RFA
OH14–002.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 1:00 p.m.–4:00 p.m.,
December 10, 2013 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to Cooperative Agreement on
Occupational Health with the World Health
Organization (WHO): Implementing World
Health Assembly Resolution 60.26 Global
Plan of Action for Workers Health 2008–
2017; RFA OH14–002.
Contact Person for More Information: Nina
Turner, Ph.D., Scientific Review Officer,
CDC, National Institute for Occupational
Safety and Health, 1095 Willowdale Road,
Morgantown, West Virginia 26506,
Telephone: (304) 285–5976.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
Notice.
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) the necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
DATES: Comments on the collection(s) of
information must be received by the
OMB desk officer by November 21,
2013.
SUMMARY:
When commenting on the
proposed information collections,
please reference the document identifier
or OMB control number. To be assured
consideration, comments and
recommendations must be received by
the OMB desk officer via one of the
following transmissions: OMB, Office of
Information and Regulatory Affairs,
Attention: CMS Desk Officer, Fax
Number: (202) 395–6974 or Email:
OIRA_submission@omb.eop.gov.
ADDRESSES:
E:\FR\FM\22OCN1.SGM
22OCN1
]]>Agencies
[Federal Register Volume 78, Number 204 (Tuesday, October 22, 2013)]
[Notices]
[Page 62636]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-24341]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
(HICPAC)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announce the following meeting for the aforementioned
committee:
Times and Dates: 9:00 a.m.-5:00 p.m., November 6, 2013; 9:00
a.m.-12:00 p.m., November 7, 2013.
Place: Centers for Disease Control and Prevention, Global
Communications Center, Building 19, Auditorium B3, 1600 Clifton Road
NE., Atlanta, Georgia 30333.
Status: Open to the public, limited only by the space available.
Please register for the meeting at www.cdc.gov/hicpac.
Purpose: The Committee is charged with providing advice and
guidance to the Director, Division of Healthcare Quality Promotion,
the Director, National Center for Emerging and Zoonotic Infectious
Diseases (NCEZID), the Director, CDC, the Secretary, Health and
Human Services regarding (1) the practice of healthcare infection
prevention and control; (2) strategies for surveillance, prevention,
and control of infections, antimicrobial resistance, and related
events in settings where healthcare is provided; and (3) periodic
updating of CDC guidelines and other policy statements regarding
prevention of healthcare-associated infections and healthcare-
related conditions.
Matters To Be Discussed: The agenda will include updates on CDC
and Division of Healthcare Quality Promotion's (DHQP's) activities
for prevention and surveillance of healthcare associated infections
(HAI) and antimicrobial resistance, and developing a process to
define core infection prevention and control methods. Also to be
discussed is the development of guidance for CDC guideline
recommendations that are categorized as ``unresolved''.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Erin Stone, M.S., HICPAC,
Division of Healthcare Quality Promotion, NCEZID, CDC, l600 Clifton
Road NE., Mailstop A-07, Atlanta, Georgia 30333. Telephone (404)
639-4045. Email: hicpac@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2013-24341 Filed 10-21-13; 8:45 am]
BILLING CODE 4163-18-P
